News | May 30, 2022
Glenmark Pharma reports revenue growth of 5.6% YoY in Q4
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
The integration and transition of the brands are expected to be completed by June 2022.
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
Subscribe To Our Newsletter & Stay Updated
